Trader stensgaard81 — Trading Ideas & Charts

, 240Long

Biofrontera Inc., BFRI, is a biopharmaceutical company that develops and provides dermatological products for the treatment of skin diseases in the US. It primarily develops therapies for non-melanoma skin cancer. It offers Ameluz, an aminolevulinic acid hydrochloride gel for the photodynamic therapy of actinic keratoses; and BF-RhodoLED, an LED lamp emitting red...

EVAX - Evaxion Biotech

EVAX

, 1DLong

stensgaard81

The Biotech company Evaxion Biotech, EVAX, who develop drugs based on AI platforms, is poised to publish data from its phase 1/2a trials of EVX-01 and EVX-02 in the first half of 2021. According to Yahoo Finance there are currently two analysts with price targets for the share, $18 and $23. Evaxion is an AI-immunology platform company decoding the human immune...

EVAX: AI and immunotherapies

EVAX

, 60Long

stensgaard81

EVAX - Evaxion Website: evaxion-biotech.com Industry: Pharma Evaxion is an AI-immunology platform company decoding the human immune system to discover and develop novel immunotherapies for cancer and infectious diseases. Evaxion have developed an AI-immunology core technology to deeply understand the biological processes relevant for engaging the immune system...

T2 Biosystems T2SARS-CoV-2™ Panel Proves Capable of Detecting th

TTOO

, 60Long

stensgaard81

T2 Biosystems T2SARS-CoV-2™ Panel Proves Capable of Detecting the Brazil P.1 Variant of the SARS-CoV-2 Virus T2 Biosystems, Inc. Thu, February 4, 2021, 10:05 PM·5 min read TTOO +7.14% Panel is capable of detecting 99.99% of all currently identified SARS-CoV-2 viruses based on sequence alignments and in silico analysis LEXINGTON, Mass., Feb. 04, 2021 (GLOBE...

SPCE possible short squeese

SPCE

, 60Long

stensgaard81

I see a potential short squeese on SPCE comming up. SPCE is massivly shorted and the stock is gaining. Short Percent of Float: 81.53 % Shares Float: 53,650,000 Short Interest (Shares Short): 43,740,000 Short Interest Ratio (Days To Cover): 3.1 % From 52-Wk High ($ 57.86): 4.50% % From 50-Day MA ($ 27.24): 54.35% % From 200-Day MA ($ 20.59): 104.27% % From 52-Wk...